Skip to main content
×
×
Home

Commentary: Care, Choice, and the Ethical Imagination

  • Fred B. Ketchum
Copyright
References
Hide All

Notes

1. Netherland J, Hansen H. White opioids: Pharmaceutical race and the war on drugs that wasn’t. BioSocieties 2017;1–22. doi: 10.1057/biosoc.2015.46.

2. Siegler, M. The doctor-patient encounter and its relationship to theories of health and disease. In: Concepts of Health and Disease: Interdisciplinary Perspectives. Reading, MA: Addison-Wesley Publishing Co.; 1981:627–44.

3. Emanuel, EJ, Emanuel, LL. Four models of the physician-patient relationship. JAMA 1992;267(16):2221–6.

4. Kahane, G, Ter Meulen, R, Savulescu, J, eds. Enhancing Human Capacities. New York: Wiley-Blackwell; 2011.

5. Allouche, S, Gayon, J, Marzano, M, Goffette, J, (Bateman, S, ed.). Inquiring into Human Enhancement: Interdisciplinary and International Perspectives. New York: Palgrave Macmillan; 2015.

6. Daniels, N. Normal functioning and the treatment-enhancement distinction. Cambridge Quarterly of Healthcare Ethics 2000;9(3):309–22.

7. Parens, E. Enhancing Human Traits? Ethical and Social Implications. Washington, DC: Georgetown University Press; 1998.

8. Coveney, CM. Cognitive enhancement? Exploring Modafinil use in social context. Advances in Medical Sociology 2011;13:203–28.

9. Maher, B. Poll results: Look who’s doping. Nature 2008;452(7188):674–5.

10. Ferrari, A, Coenen, C, Grunwald, A. Visions and ethics in current discourse on human enhancement. NanoEthics 2012;6(3):215–9.

11. Nichter, M. Generation RX: Anthropological research on pharmaceutical enhancement, lifestyle regulation, self-medication and recreational drug use. In: Singer, M, Erickson, PI, eds. A Companion to Medical Anthropology, Blackwell Companions to Anthropology. Malden, MA: Wiley-Blackwell; 2011:338–55.

12. Partridge, BJ, Bell, SK, Lucke, JC, Yeates, S, Hall, WD. Smart drugs ‘as common as coffee’: Media hype about neuroenhancement. PLoS One 2011;(6)11: e28416.

13. Forlini, C, Partridge, B, Lucke, J, Racine, E. Popular media and bioethics scholarship: Sharing responsibility for portrayals of cognitive enhancement with prescription medications. In: eds. Clausen, J, Levy, N. Handbook of Neuroethics, New York, NY: Springer Dordrecht; 2015:1473–86.

14. Desantis, AD, Hane, AC. ‘Adderall Is definitely not a drug’ justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 2010;45(1–2):3146.

15. Mol, A. The Logic of Care: Health and the Problem of Patient Choice. London: Routledge; 2008.

16. Ilieva, IP, Farah, MH. Enhancement stimulants: Perceived motivational and cognitive advantages. Neuropharmacology 2013;7:198.

17. Repantis, D, Schlattmann, P, Laisney, O, Heuser, I. Modafinil and Methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research 2010;62(3):187206.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Cambridge Quarterly of Healthcare Ethics
  • ISSN: 0963-1801
  • EISSN: 1469-2147
  • URL: /core/journals/cambridge-quarterly-of-healthcare-ethics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed